Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients

Clinical Immunology

Volumn 132, Issue 2, 2009, Pages 285-290

  Buraczynska, Monika ^a   Ksiazek, Piotr ^a   Zukowski, Pawel ^a   Benedyk Lorens, Ewa ^b   Orlowska Kowalik, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Dialysis Center Fresenius NephroCare II   (Poland)

Author keywords

Association study; Cardiovascular disease; Complement factor H; End stage renal disease; Gene polymorphism; Risk factor

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; ALLELES; CARDIOVASCULAR DISEASES; COMPLEMENT FACTOR H; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67649998517     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.04.005     Document Type: Article

References (26)

1. Levey A.S., Beto J.A., and Coronado B.E. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here. Am. J. Kidney Dis. 32 (1998) 853-906
2. Cheung A.K., Sarnak M.J., and Yan C. Cardiac diseases in maintenance hemodialysis patients : results of the HEMO study. Kidney Int. 65 (2004) 2380-2389
3. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. New Engl. J. Med. 352 (2005) 1685-1695
4. Yan Z., and Hansson G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 219 (2007) 187-203
5. Oksjoki R., Kovanen P.T., Meri S., and Pentikainen M.O. Function and regulation of the complement system in cardiovascular diseases. Front. Biosci. 12 (2007) 4696-4708
6. Bjerre M., Hansen T.K., and Flyvbjerg A. Complement activation and cardiovascular disease. Horm. Metab. Res. 40 (2008) 626-634
7. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 421-424
8. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41 (2004) 355-367
9. Rodriguez de Cordoba S., and Goicoechea de Jorge E. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151 (2008) 1-13
10. Zee R.Y.L., Diehl K.A., and Ridker P.M. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187 (2006) 332-335
11. Kardys I., Klaver C.C., Despriet D.D., Bergen A.A., Uitterlinder A.G., Hofman A., Oostra B.A., Van Duijn C.M., de Jong P.T., and Witteman J.C.M. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction. J. Am. Coll. Cardiol. 47 (2006) 1568-1575
12. Mooijaart S.P., Koeijvoets K.M., Sijbrands E.J.G., Daha M.R., and Westendorp R.G.J. Complement factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large. Exp. Gerontol. 42 (2007) 1116-1122
13. Nicaud V., Francomme C., Ruidavets J.-B., Luc G., Arveiler D., Kee F., Evans A., Morrison C., Blankenberg S., Cambien F., and Tiret L. Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction. J. Mol. Med. 85 (2007) 771-775
14. Stark K., Neureuther K., Sedlacek K., Hengstenberg W., Fischer M., Baessler A., Wiedmann S., Jeron A., Holmer S., Erdmann J., Schunkert H., and Hengstenberg C. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clin. Sci. 113 (2007) 213-218
15. Wegscheider B.J., Weger M., Renner W., Steinbrugger I., März W., Mossböck G., Temmel W., El-Shabrawi Y., Schmut O., Jahrbacher R., and Haas A. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114 (2007) 738-742
16. Droz I., Mantel I., Ambresin A., Faouzi M., Schorderet D.F., and Munier F.L. Genotype-phenotype correlation of age-related macular degeneration : influence of complement factor H polymorphism. Br. J. Ophthalmol. 92 (2008) 513-517
17. Schunkert H., König I.R., and Erdmann J. Molecular signatures of cardiovascular disease risk : potential for test development and clinical application. Mol. Diagn. Ther. 12 (2008) 281-287
18. Topol E.J., Smith J., Plow E.F., and Wang Q.K. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15 (2006) R117-R123
19. Buraczynska M., Mierzicki P., Buraczynska K., Dragan M., and Ksiazek A. Tumor necrosis factor-α gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol. Diagn. Ther. 11 (2007) 257-263
20. Pernod G., Bosson J.L., Golshayan D., Barro C., Fomeris G., Martina G., Bonfant G., Hurot J.M., Turc-Baron C., Jouet C., Theyfaz J., Jeantet A., Wauters J.P., and Cordonnier D. Diamant Alpin Collaborative Dialysis Study Group, phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort. Kidney Int. 69 (2006) 1424-1430
21. Szeto C.C., Chow K.M., Poon P.Y., Kwan B.C., and Li P.K. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy. Am. J. Nephrol. 28 (2008) 715-722
22. Blackmore T.K., Fischetti V.A., Sadlon T.A., Ward H.M., and Gordon D.L. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect. Immun. 66 (1998) 1427-1431
23. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., Sangiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
24. Qian Q., Chen Z., Ma G., Jiang Y., Feng Y., Shen C., Yao Y., Ding J., Dai Q., and Li Y. Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease. Mol. Biol. Rep. (2008) 10.1007/s11033-008-9306-4
25. Kardys I., de Maat M.P., Klaver C.C., Despriet D.D., Uitterlinden A.G., Hofman A., de Jong P.T., and Vitteman J.C. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study). Am. J. Cardiol. 100 (2007) 646-648
26. Pai J.K., Manson J.E., Rexrode K.M., Albert C.M., Hunter D.J., and Rimm E.B. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur. Heart J. 28 (2007) 1297-1303